Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transgene Biotek Ltd has informed BSE that Regulation 57(5) of SEBI (LODR) Regulations, 2015 does not apply to the company for the quarter ended 31st December 2025. The regulation relates to disclosures around interest, dividend, and principal payments on non-convertible securities. The company clarified it has not issued any non-convertible securities, making the regulation inapplicable. Both the certificate of payment and details of unpaid obligations on such securities are marked as 'Not Applicable'.
This is a routine compliance filing with no material impact on shareholders or the stock price. It simply confirms that a specific regulation governing non-convertible securities does not apply to the company.